Evidence map›Paper›PMID 23733245›Full record

ArticleNeuro-oncology2013

Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis.

Kyle M Walsh, Terri Rice, Paul A Decker, Matthew L Kosel, Thomas Kollmeyer, Helen M Hansen, Shichun Zheng, Lucie S McCoy, Paige M Bracci, Erik Anderson and 15 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Neuro-oncology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 50 citations in OpenAlex.

  1. Telomere length and risk of glioma.Cancer epidemiology · 2013
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Association ofPharmacogenomics and personalized medicine · 2021
    Article
  8. Article
  9. Journal of medical genetics · 2020
    Article
  10. Clinical Significance of Various Classification Standards of Age Groups in Predicting Survival of Patients with Glioblastoma.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Clinical and Genetic Risk Prediction of Subsequent CNS Tumors in Survivors of Childhood Cancer: A Report From the COG ALTE03N1 Study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2017
    Article
  15. Article
  16. Article
  17. Genetic Variation Associated with Longer Telomere Length Increases Risk of Chronic Lymphocytic Leukemia.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2016
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 6 institutions in 1 country.

Kyle M WalshDepartment of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA. kyle.walsh@ucsf.edu
Terri Rice
Paul A Decker
Matthew L Kosel
Thomas Kollmeyer
Helen M Hansen
Shichun Zheng
Lucie S McCoy
Paige M Bracci
Erik Anderson
George Hsuang
Joe L Wiemels
Alexander R Pico
Ivan Smirnov
Annette M Molinaro
Tarik Tihan
Mitchell S Berger
Susan M Chang
Michael D Prados
Daniel H Lachance
Hugues Sicotte
Jeanette E Eckel-Passow
John K Wiencke
Robert B Jenkins
Margaret R Wrensch
Cancer Genetics (United States) · USUniversity of California, San Francisco · USGladstone Institutes · USMayo Clinic · USNeurological Surgery · USUCSF Helen Diller Family Comprehensive Cancer Center · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
Tissue CoreP50CA097257 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Joseph F Costello · 2002 to 2026
$57.4M
Targeted MV-CEA as a Potent Antitumor Agent against GBMP50CA108961 · NCI · MAYO CLINIC ROCHESTER · PI O'NEILL, BRIAN PATRICK · 2004 to 2015
$22.5M
CALIFORNIA'S PARTICIPATION IN THE NATIONAL CANCER PREVENTION AND CONTRO PROGRAMU58DP000807 · DP · PUBLIC HEALTH INSTITUTE · PI SNIPES, KURT P · 2007 to 2011
$22.5M
GENETIC EPIDEMIOLOGY OF MALIGNANT GLIOMAR01CA052689 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WIENCKE, JOHN K., WRENSCH, MARGARET R. · 1991 to 2015
$20.5M
Training in Molecular& Genetic Epidemiology of CancerR25CA112355 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WITTE, JOHN S. · 2005 to 2018
$6.5M
Identification of 9p and 20q Germline Alterations in Glioblastoma PathogenesisRC1NS068222 · NINDS · MAYO CLINIC ROCHESTER · PI JENKINS, ROBERT B. · 2009 to 2010
$984k
NCCDPHP CDC HHS 1U58 DP000807-01NCCDPHP CDC HHS U58 DP000807NCI NIH HHS HHSN261201000034CNCI NIH HHS HHSN261201000035CNCI NIH HHS HHSN261201000035INCI NIH HHS HHSN261201000036CNCI NIH HHS P30 CA015083NCI NIH HHS P30 CA15083NCI NIH HHS P50 CA097257NCI NIH HHS P50CA097257NCI NIH HHS P50 CA108961NCI NIH HHS P50CA108961NCI NIH HHS R01 CA052689NCI NIH HHS R01CA52689NCI NIH HHS R25 CA112355NCI NIH HHS R25CA112355NINDS NIH HHS RC1 NS068222NINDS NIH HHS RC1NS068222Z
6 · The paper itself

Abstract

backgroundGenome-wide association studies have implicated single nucleotide polymorphisms (SNPs) in 7 genes as glioma risk factors, including 2 (TERT, RTEL1) involved in telomerase structure/function. We examined associations of these 7 established glioma risk loci with age at diagnosis among patients with glioma.

methodsSNP genotype data were available for 2286 Caucasian glioma patients from the University of California, San Francisco (n = 1434) and the Mayo Clinic (n = 852). Regression analyses were performed to test for associations between "number of risk alleles" and "age at diagnosis," adjusted for sex and study site and stratified by tumor grade/histology where appropriate.

resultsFour SNPs were significantly associated with age at diagnosis. Carrying a greater number of risk alleles at rs55705857 (CCDC26) and at rs498872 (PHLDB1) was associated with younger age at diagnosis (P = 1.4 × 10(-22) and P = 9.5 × 10(-7), respectively). These SNPs are stronger risk factors for oligodendroglial tumors, which tend to occur in younger patients, and their association with age at diagnosis varied across tumor subtypes. In contrast, carrying more risk alleles at rs2736100 (TERT) and at rs6010620 (RTEL1) was associated with older age at diagnosis (P = 6.2 × 10(-4) and P = 2.5 × 10(-4), respectively). These SNPs are risk factors for all glioma grades/histologies, and their association with age at diagnosis was consistent across tumor subgroups.

conclusionsCarrying a greater number of risk alleles might be expected to decrease age at diagnosis. However, glioma susceptibility conferred by variation in telomerase-related genes did not follow this pattern. This supports the hypothesis that telomerase-related mechanisms of telomere maintenance are more associated with gliomas that develop later in life than those utilizing telomerase-independent mechanisms (ie, alternative lengthening of telomeres).

Indexed as

AdultAgedAge FactorsBiomarkers, TumorBrain NeoplasmsCase-Control StudiesDNA HelicasesFemaleFollow-Up StudiesGenetic Predisposition to DiseaseGenotypeGliomaHumansMaleMiddle AgedNeoplasm GradingBiomarkers, TumorDNA HelicasesRTEL1 protein, humanTelomeraseTERT protein, humanage at diagnosisgliomasingle nucleotide polymorphismtelomerasetelomere

Identifiers

PMID23733245
PMCPMC3714154
OpenAlexW2011894007

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.